Alliancebernstein L.P. Infinity Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $7,938 - $19,440	-16,200 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.85 - $2.4 $85 - $240	100 Added 0.62%	16,200 $18,000
Q2 2021 Jul 30, 2021	BUY	$2.66 - $3.47 $42,826 - $55,867	16,100 New	16,100 $48,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.